Removing less potent T cell subsets as well as poorly- or non-engineered cells can optimize effectiveness of engineered T cell therapy against cancer. We have recently described a novel, GMP-ready method for the purification of engineered immune cells that might further boost the clinical success of cancer immunotherapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801490 | PMC |
| http://dx.doi.org/10.1080/2162402X.2015.1076608 | DOI Listing |
Publication Analysis
Top Keywords
engineered immune
8
immune cells
8
step gmp-grade
4
gmp-grade production
4
production engineered
4
cells removing
4
removing potent
4
potent cell
4
cell subsets
4
subsets well
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!